CD20 (+) B cells in the tumor microenvironment can produce IFN-γ, interleukin 12p40, granzyme B, and TRAIL and acted in cooperation with CD8 (+) T cells to promote tumor immunity and predict good prognosis in HCC [34]. The gene discussed is CD8A; the disease is neoplasm.